# Nicotinic Acid Composition of HDL and Arterial Endothelium Function in Premature Coronary Heart Disease and High HDL

> **NCT01450410** · PHASE4 · TERMINATED · sponsor: **Xavier Pinto Sala** · enrollment: 12 (actual)

## Conditions studied

- Dyslipidemias

## Interventions

- **DRUG:** Nicotinic acid
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01450410
- **Lead sponsor:** Xavier Pinto Sala
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-07
- **Primary completion:** 2013-03
- **Final completion:** 2013-05
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** Study terminated (halted prematurely) as recomended by the drug supplier and medical agencies
- **Last updated:** 2013-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01450410

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01450410, "Nicotinic Acid Composition of HDL and Arterial Endothelium Function in Premature Coronary Heart Disease and High HDL". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01450410. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*